{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:45:36Z","timestamp":1778543136032,"version":"3.51.4"},"reference-count":22,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,5,9]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Premature rupture of membranes (PROM) occurs at term in 8% of pregnancies. Several studies have demonstrated that the risk of chorioamnionitis and neonatal sepsis increases with duration of PROM. Decreasing the time interval between PROM and delivery is associated with lower rates of maternal infections. In case of an unfavourable cervix, the use of prostaglandin for cervical maturation demonstrates some advantages over oxytocin. The use of double balloon catheter in reduction of PROM duration has not been evaluated in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We are conducting a prospective, monocentric, randomised clinical trial on pregnant women with an unfavourable cervix showing PROM at term (RUBAPRO).<\/jats:p>\n                    <jats:p>After 12\u201324\u2009hours of PROM, women are randomly assigned to one group treated with a double balloon catheter for 12\u2009hours, with oxytocin administered after 6\u2009hours or to the control group treated with 24\u2009hours of vaginal prostaglandin followed by oxytocin infusion alone. Patients (n=80) are randomised at a 1:1 ratio with stratification on parity.<\/jats:p>\n                    <jats:p>The inclusion criteria are a Bishop score of &lt;6, cephalic presentation at term and confirmed PROM. Women with suspected chorioamnionitis; group B streptococcus (GBS) carrier; a history of caesarean delivery or any contraindication for vaginal delivery are excluded.<\/jats:p>\n                    <jats:p>The time from induction to delivery is the primary outcome. Secondary outcomes were mode of delivery, maternofetal morbidity and the effect of parity on strategies for reduction of PROM duration.<\/jats:p>\n                    <jats:p>To sufficiently demonstrate a difference (10 hours) between groups\u2014with a statistical power of 90% and a two-tailed \u03b1 of 5%\u201440 patients per group will be required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Written informed consent is required from participants.<\/jats:p>\n                    <jats:p>National Ethics Committee approval was obtained in August 2017. The results will be published in a peer-reviewed journal and presented at relevant conferences. Access to raw data will be available only to members of the research team.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT03310333\" ext-link-type=\"clintrialgov\">NCT03310333<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-026090","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:17:06Z","timestamp":1561097826000},"page":"e026090","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Induction of labour in case of premature rupture of membranes at term with an unfavourable cervix: protocol for a randomised controlled trial comparing double balloon catheter (+oxytocin) and vaginal prostaglandin (RUBAPRO) treatments"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03310333","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03310333","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eric","family":"Devillard","sequence":"first","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Delabaere","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"},{"name":"\u2019Translational approach to epithelial injury and repair' team, Auvergne University, CNRS, Inserm, GReD, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Rouzaire","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[{"name":"Biostatistics 1 Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Accoceberry","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Houlle","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydie","family":"Dejou-Bouillet","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Bouchet","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Gallot","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"},{"name":"\u2019Translational approach to epithelial injury and repair' team, Auvergne University, CNRS, Inserm, GReD, Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"2025121219560952000_9.6.e026090.1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0002-9378(70)90378-9","article-title":"Premature rupture of the fetal membranes. A review","volume":"106","author":"Gunn","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"2025121219560952000_9.6.e026090.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341601"},{"key":"2025121219560952000_9.6.e026090.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70007-3"},{"key":"2025121219560952000_9.6.e026090.4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.gofs.2017.05.001","article-title":"Pr\u00e9diction de l\u2019entr\u00e9e en travail sous 24 heures en cas de rupture des membranes \u00e0 terme","volume":"45","author":"Huret","year":"2017","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"},{"key":"2025121219560952000_9.6.e026090.5","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b48ef5"},{"key":"2025121219560952000_9.6.e026090.6","first-page":"CD000159","article-title":"Prostaglandins versus oxytocin for prelabour rupture of membranes at term","volume":"2","author":"Tan","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121219560952000_9.6.e026090.7","first-page":"CD005302","article-title":"Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)","volume":"04","author":"Middleton","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121219560952000_9.6.e026090.8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/14767058.2015.1027191","article-title":"Use of intracervical balloons and chorioamnionitis in term premature rupture of membranes","volume":"29","author":"Cabrera","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025121219560952000_9.6.e026090.9","doi-asserted-by":"crossref","first-page":"360.e1","DOI":"10.1016\/j.ajog.2017.04.038","article-title":"A randomized trial of Foley Bulb for Labor Induction in\u00a0Premature Rupture of Membranes in Nulliparas (FLIP)","volume":"217","author":"Amorosa","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2025121219560952000_9.6.e026090.10","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2014.137"},{"key":"2025121219560952000_9.6.e026090.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000009986","article-title":"Balloon catheter for induction of labor in nulliparous women with prelabor rupture of the membranes at term. A preliminary report","volume":"46","author":"Wolff","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"2025121219560952000_9.6.e026090.12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0000000000002374","article-title":"Foley Plus Oxytocin Compared With Oxytocin for Induction After Membrane Rupture: A Randomized Controlled Trial","volume":"131","author":"Mackeen","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2025121219560952000_9.6.e026090.13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ajog.2010.04.038","article-title":"Foley catheter balloon vs locally applied prostaglandins for cervical ripening and labor induction: a systematic review and metaanalysis","volume":"203","author":"Vaknin","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2025121219560952000_9.6.e026090.14","first-page":"CD003101","article-title":"Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term","volume":"6","author":"Thomas","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121219560952000_9.6.e026090.15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/AOG.0000000000001002","article-title":"Evaluation of a Transcervical Foley Catheter as a Source of Infection: A Systematic Review and Meta-analysis","volume":"126","author":"McMaster","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2025121219560952000_9.6.e026090.16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jog.13551","article-title":"Double-balloon versus single-balloon catheter for cervical ripening and labor induction: A systematic review and meta-analysis","volume":"44","author":"Yang","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"2025121219560952000_9.6.e026090.17","unstructured":"Lajusticia H , Mart\u00ednez-Dom\u00ednguez SJ , P\u00e9rez-Roncero GR , et al . Project THO and SA (HOUSSAY). Single versus double-balloon catheters for the induction of labour of singleton pregnancies: a meta-analysis of randomized and quasi-randomized controlled trials. Arch Gynecol Obstet 2018:1\u201312."},{"key":"2025121219560952000_9.6.e026090.18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0036-1580608","article-title":"Foley Catheter or Oral Misoprostol for Induction of Labor in Women with Term Premature Rupture of Membranes: A Randomized Multicenter Trial","volume":"33","author":"Kruit","year":"2016","journal-title":"Am J Perinatol"},{"key":"2025121219560952000_9.6.e026090.19","unstructured":"Cook Medical. Cervical ripening balloon with stylet. 2016 https:\/\/www.cookmedical.com\/data\/resources\/RH-D25085-FRCA-F_M3_1463771416666.pdf"},{"key":"2025121219560952000_9.6.e026090.20","unstructured":"HAS. Recommandation de bonne pratique. Avril. D\u00e9clenchement artificiel du travail \u00e0 partir de 37 semaines d\u2019am\u00e9norrh\u00e9e. 2008 https:\/\/www.has-sante.fr\/portail\/jcms\/c_666473\/fr\/declenchement-artificiel-du-travail-a-partir-de-37-semaines-d-amenorrhee"},{"key":"2025121219560952000_9.6.e026090.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.06.020"},{"key":"2025121219560952000_9.6.e026090.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-026090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:56:21Z","timestamp":1765598181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-026090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,20]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/bmjopen-2018-026090"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-026090","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}